12:00 AM
 | 
Apr 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Avioq HTLV-I/II Microelisa System regulatory update

FDA approved Avioq's Avioq HTLV-I/II Microelisa System to detect antibodies to human T lymphotropic virus Type I (HTLV-I) and Type II (HTLV-II) in blood...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >